We had a great time at #TheSPACConference hosted by @DealFlowEvents — it was an outstanding event! Thanks to all who made it possible! Need assistance with #SECFilings, #Print, #Mailing, or #VDR Services? Contact us directly: thenuvogroup.com

#SPACConference 2026, what two days! Great conversations, meaningful connections, and plenty to take away. We attended as sponsors this year, with our COO @FollowBalaji on stage for the panel discussion around the evolving regulatory and governance landscape in the SPAC and IPO space, alongside Sales Heads Globense Ouseph and Saul Grossel working the floor across both days. Thank you to everyone who stopped by the @DataTracks table to chat about SPACs, De-SPACs, and everything in between. It's conversations like these that make showing up so worthwhile. Big Thanks to @DealFlowEvents team and special thanks to Brooke Greiff Steve Evans Morgan Cropsey and Lenny La Sala for making our journey smooth. We'll be sharing highlights and reflections over the coming weeks. So watch this space! #DataTracks #SPACConference2026 #SPAC #CapitalMarkets #DeSPAC

@DealFlowEvents Predict Conference Oct 6-7 2026 The event brings together Web3 founders, traders, researchers, and AI-focused builders working at the intersection of crypto and forecasting

The SPAC Conference 2026 returns to Westchester Country Club on June 9-10, with two days of programming and, new this year, schedulable 1-on-1 meetings for sponsors and de-SPAC targets. The SPAC Conference 2026 returns to the Westchester Country Club in New York for two days of programming on Tuesday and Wednesday, June 9-10, 2026, hosted by DealFlow Events. The SPAC Conference 2026 is a B2i Digital (@b2idigital) Featured Conference. For more details, please visit: b2idigital.com/dealflow-even… The two-day program brings together investment bankers, institutional investors, SPAC sponsors, and service professionals from across the SPAC and de-SPAC ecosystem. Sessions cover regulatory and structural shifts shaping today's market, valuation and PIPE trends, cross-border transactions, litigation and enforcement themes, IR and post-listing market support, and what private targets should evaluate before choosing a SPAC partner. New this year, the conference is offering 1-on-1 meetings that can be scheduled in advance, designed for SPAC sponsors and private company executives considering a SPAC route to the public markets. Agenda coverage spans: - Regulatory clarity and SEC enforcement priorities for SPACs and de-SPACs - Disclosure liability, sponsor and director exposure, and litigation risk management - Earnout structures and risk-adjusted valuations in today's rationalized market - Cross-border SPAC listings, U.S. liquidity access, and global PIPE participation - IR strategy, analyst coverage, lock-up dynamics, and post-listing market support - Governance standards, board independence, and sponsor-promote alignment DealFlow Events (@DealFlowEvents) has produced more than 200 conferences, seminars, and webcasts over the past 20 years, with programs recognized for content depth and quality of networking across the financial markets it covers. Event details and registration are available at spacconference.com and dealflowevents.com. A sincere thank you to the DealFlow conference team whose hard work and dedication make events like this possible: Steven Dresner, Phillip LoFaso, Brooke Greiff, PJ Daniels, Lenny La Sala, and Morgan Cropsey. Their efforts behind the scenes deserve every bit of recognition. About B2i Digital, B2i Digital connects emerging growth companies with sector-focused investors through digital marketing campaigns and a curated network of Featured Companies, Featured Experts, and Featured Conferences. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at b2idigital.com. Disclosure: B2i Digital, Inc. is a marketing partner of The SPAC Conference 2026. B2i Digital is not an affiliate of DealFlow Events and is not authorized to represent or act on behalf of DealFlow Events in any capacity. DealFlow Events has not reviewed or approved the content of this post. Content about any specific company was provided and approved by that company or is available in the public domain.

Began my morning in NYC telling everyone why I hate venture debt 😆 more to come.. @DealFlowEvents venture debt conference!

From his @DealFlowEvents Discovery Conference interview, $KAPA's CSO Neil Bhowmick shares Phase 1 insights on ENV105 in EGFR-driven #lungcancer Early data shows strong safety and promising efficacy in non-smokers. Full interview: bit.ly/474T25e #DealFlowDiscovery

At this year's @DealFlowEvents Discovery Conference,  $KAPA's CSO, Neil Bhowmick, discussed the Company’s strategy to extend the effectiveness of existing cancer therapies and the potential of ENV105 in prostate and lung cancer. Watch the interview: bit.ly/474T25e #DealFlowDiscovery

🧠🐾 AgenticPet Quiz, Round 4! Let’s see who’s been keeping up with the latest. 👇 1️⃣ Who is the CEO of PetVivo Holdings? A) John Lai B) Steven Holtzman C) Elon Musk D) Brian Armstrong 2️⃣ Which conference did the AgenticPet team attend back in January? A) Consensus B) Token2049 C) DealFlowEvents D) ETHDenver 3️⃣ How many Beta access codes have users redeemed so far? A) ~11K B) ~26K C) ~37K D) ~50K Drop your answers in the comments. Let’s see who the real AgenticPet insiders are! 🚀🐶🐱

🚀 January Recap - Big Moves Made ✅Launched our Open Beta 🐾 ✅Shared 3,000 Beta access codes 🎟️ ✅Passed 2,000 active Beta users 🔥 ✅Ran growth experiments with @zealy_io 🧪 ✅Teamed up with @mugshot_vet 🤝 ✅Announced upcoming Web3 integrations 🌐 ✅Unveiled the token that will power the AgenticPet's AI framework 🪙 ✅Attended @DealFlowEvents conference 🎤 ✅Had a blast at X Spaces together with @Cryptoze More cooking. Next month goes even harder! 🚀

Today kicks off the @DealFlowEvents Discovery Conference at the @BorgataAC. Excited for our Chief Scientific Officer, Neil Bhowmick, to deliver $KAPA's company presentation. #DealFlowDiscovery

“We’ve been under the radar. Even as we continue to generate new data and news flow and some real progress across the business. We want to make sure people know what we’re doing, follow, get excited and join the party.” $DRTS CFO Raphi Levy, on Presenting and Meeting Investors at the #dealflowdiscovery Conference. @DealFlowEvents @askadamtorres @bigmoneymatters

Time is up and looks like we have our first winner! @TheMrKnight_ reach out to @allagainstme and claim your precious prize! Keep an eye on upcoming tweets, more chances are on the way! 😇

Our team is busy - out and about telling the $SALT.V story across North America! CFO, Jeffrey Kilborn will be attending & presenting at the @DealFlowEvents #DiscoveryConference in Atlantic City! Presentation: 12:30 pm on January 28th 🗓️ Reach out ➡️ investors@atlassalt.com 🤝

Would be great to see more competitiveness here. Dive in! Give some good comments, engage and spread the word! @DealFlowEvents is a truly big deal for us and your support as pet lover is mandatory! Let's reshape the future together 🐾🚀

First winner will be announced in ~12h from now!

世界の決済市場は2029年に3兆ドル超へ。🌍 OBOOK ($OWLS) CEOの @owltingdarren が @RedChip で、グローバル商取引を支えるコンプライアンス型ステーブルコイン基盤の拡大を語ります。🦉💳 明日からの @DealFlowEvents でお会いしましょう！ #OWLS #Nasdaq

The "2026 Vision" The global payments market is hitting $3.0T by 2029. 🌍 CEO @owltingdarren joins @RedChip to discuss how OBOOK Holdings ($OWLS) is scaling compliance-first stablecoin rails for global commerce. 🦉💳 See us at @DealFlowEvents Discovery tomorrow!

The team at @b2idigital welcomes @jupiterneuro (NASDAQ: $JUNS) as a new Featured Company. Jupiter Neurosciences will be presenting at the 3rd Annual @DealFlowEvents Discovery Conference, a B2i Digital Featured Conference, on January 28-29, 2026 at The Borgata in Atlantic City, NJ. Christer Rosén, Founder, Chairman and CEO, will deliver the presentation and be available for one-on-one investor meetings. A dedicated profile of the company will be available soon. Based in Jupiter, Florida, Jupiter Neurosciences is a clinical-stage pharmaceutical company built around JOTROL™, a patented resveratrol formulation that has demonstrated nine times greater bioavailability than earlier versions of the compound. The company operates a dual-path business model: advancing a therapeutic pipeline targeting neuroinflammation and CNS disorders while commercializing Nugevia™, a premium longevity supplement line using the same delivery technology. On the pharmaceutical side, the FDA cleared the company’s IND application in November 2025, authorizing a Phase 2a clinical trial in Parkinson’s disease with patient enrollment expected in early 2026. The company is also exploring potential applications in Alzheimer’s disease, Friedreich’s Ataxia, Mucopolysaccharidoses Type I, and MELAS. Research collaborations include partnerships with Harvard, Georgetown, MIT’s Picower Institute, and the University of Miami. Jupiter Neurosciences’s consumer business launched in 2025 with three Nugevia products (GLO, PWR, and MND), each targeting pillars of healthy aging: skin vitality, mitochondrial energy, and cognitive resilience. Brand ambassadors include golf icon Annika Sörenstam, NBA legend Chris Webber, and biohacker Jean Fallacara. Jupiter completed its IPO in December 2024 and has since secured access to up to $20 million in flexible capital through Yorkville Advisors to fund clinical development and commercial expansion. The company is led by Christer Rosén, Founder, Chairman and CEO; Alison D. Silva, President and CBO; Saleem Elmasri, CPA, CFO; Marshall Hayward, Ph.D., Co-Founder and CSO; Alexander Rosén, Co-Founder and CAO; Dr. Claes Wahlestedt, MD, Ph.D., Co-Founder and Consulting CMO; and Shaun P. Brothers, Ph.D., Co-Founder and Consulting Head of Scientific Research. To learn more about Jupiter Neurosciences. For investor inquiries, contact IR@jupiterneurosciences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences.

really looking forward to what’s to come👏

that’s cool